Penumbra, Inc. (PEN)
327.95
-1.94
(-0.59%)
USD |
NYSE |
Apr 27, 16:00
327.95
0.00 (0.00%)
After-Hours: 20:00
Penumbra EPS Diluted (Quarterly) : 1.202 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.897 |
| Abbott Laboratories | 0.6165 |
| Globus Medical, Inc. | 1.029 |
| Insulet Corp. | 1.441 |
| Stryker Corp. | 2.197 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 47.34M |
| Revenue (Quarterly) | 385.38M |
| Total Expenses (Quarterly) | 338.04M |
| Enterprise Value | 12.62B |
| Gross Profit Margin (Quarterly) | 66.88% |
| Profit Margin (Quarterly) | 12.28% |
| Earnings Yield | 1.38% |
| Operating Earnings Yield | 1.47% |
| Normalized Earnings Yield | 1.379 |